Nav: Home

Could a pure maple syrup extract be tapped for better brain health?

March 14, 2016

San Diego, CA - March, 14 2016 - As part of a two-day symposium at the annual meeting of the American Chemical Society, a group of international scientists shared promising results of 24 studies exploring the beneficial effects of natural products on the prevention of neurodegenerative diseases, particularly Alzheimer's disease. For the first time at this symposium, real maple syrup was included among the healthful, functional foods that show promise in protecting brain cells against the kind of damage found in Alzheimer's disease.

One study presented by Dr. Donald Weaver, from the Krembil Research Institute of the University of Toronto, found that an extract of maple syrup may help prevent the misfolding and clumping of two types of proteins found in brain cells - beta amyloid and tau peptide. When cellular proteins fold improperly and clump together, they accumulate and form the plaque that is involved in the pathogenesis of Alzheimer's and other brain diseases.

The other research presented at the symposium showed that a pure maple syrup extract prevented the fibrillation (tangling) of beta amyloid proteins and exerted neuroprotective effects in rodent's microglial brain cells. Scientists have found that a decrease in microglial brain cell function is associated with Alzheimer's disease and other neurological problems. The maple syrup extract also prolonged the lifespan of an Alzheimer's roundworm model in vivo. The study was conducted out of the University of Rhode Island, in collaboration with researchers at Texas State University, and was led by Dr. Navindra P. Seeram, the symposium's organizer.

"Natural food products such as green tea, red wine, berries, curcumin and pomegranates continue to be studied for their potential benefits in combatting Alzheimer's disease. And now, in preliminary laboratory-based Alzheimer's disease studies, phenolic-enriched extracts of maple syrup from Canada showed neuroprotective effects, similar to resveratrol, a compound found in red wine," said Dr. Seeram. "However, further animal and eventually human studies would be required to confirm these initial findings."

These preliminary findings help support discoveries made over the past few years on the inherent properties of pure maple syrup that comes directly from the sap of the maple tree, making it an all-natural product with unique health benefits.

Serge Beaulieu, President of the Federation of Quebec Maple Syrup Producers, is excited by the findings of the independent scientific studies and enthusiastic about the potential pure maple syrup may have on neurological health. "The Federation and the 7300 Quebec maple enterprisers are committed to investing in scientific research to help better understand the link between food and health. This has been demonstrated by a robust and carefully guided research program that started in 2005 to explore the potential health benefits of pure maple syrup," said Beaulieu. "We already know that maple has more than 100 bioactive compounds, some of which have anti-inflammatory properties. Brain health is the latest topic of exploration and we look forward to learning more about the potential benefits that maple syrup might have in this area."

Alzheimer's disease is a progressive, neurodegenerative disease that impairs daily functioning through gradual loss of memory. Alzheimer's has no current cure, but treatments for symptoms are available and research continues. According to the Alzheimer's Association, every 67 seconds, someone in the U.S. develops Alzheimer's disease, a condition that currently cannot be cured, prevented or even slowed. It is the sixth leading cause of death in the U.S., afflicts 11 percent of the U.S. population over the age of 65, and carries with it an annual health care cost of $226 billion (2015 estimate).

The Federation of Quebec Maple Syrup Producers does not promote an increase of sugar consumption. When choosing a sweetener for moderate use, pure maple syrup has more healthful compounds compared to some other sources of sugar.
-end-
About the Federation of Quebec Maple Syrup Producers and Maple Products from Quebec

Since 1966, the Federation of Quebec Maple Syrup Producers (FPAQ) has pursued its mission of defending and promoting the economic, social and moral interests of 7,300 maple enterprises in Quebec, men and women working together to establish standards of quality and see to the promotion and collective marketing of their products. Quebec is responsible for 90 percent of maple syrup production in Canada and approximately 71 percent of all maple production in the entire world. Together, Ontario, New Brunswick and Nova Scotia account for 10 percent of Canadian production.

FPAQ proudly promotes the Maple Products from Quebec brand and coordinates the marketing and development of Canadian maple products to the world on behalf of the Canadian maple industry. To these ends, FPAQ leads and gives direction to an international innovation network for maple products from Canada.

PadillaCRT

Related Neurodegenerative Diseases Articles:

Researchers identify link between birth defect and neurodegenerative diseases
A new study has found a link between neurological birth defects in infants commonly found in pregnant women with diabetes and several neurodegenerative diseases, including Alzheimer's, Parkinson's and Huntington's diseases.
High school football players, 1956-1970, did not have increase of neurodegenerative diseases
A Mayo Clinic study published online today in Mayo Clinic Proceedings found that varsity football players from 1956 to 1970 did not have an increased risk of degenerative brain diseases compared with athletes in other varsity sports.
Researchers reveal how neurodegenerative diseases spread through the brain
Synapses, the place where brain cells contact one another, play a pivotal role in the transmission of toxic proteins.
Untangling a cause of memory loss in neurodegenerative diseases
In mice genetically engineered to mimic aspects of human tauopathy disorders, the researchers restored some of the learning and memory deficits by blocking caspase-2 activity, which suggests that some of the cognitive loss seen in tauopathies might be reversible.
New impetus for treatment neurodegenerative diseases
Twenty years ago, tumor necrosis factor (TNF) seemed a promising target in the treatment of brain diseases like multiple sclerosis or Alzheimer's Disease.
Study demonstrates role of gut bacteria in neurodegenerative diseases
Research has revealed that exposure to bacterial proteins called amyloid that have structural similarity to brain proteins may lead to an increase in clumping of proteins in the brain.
How do the bugs in your gut affect neurodegenerative and psychiatric diseases?
A growing body of scientific and medical evidence continues to shed light on the complex interaction between metabolic pathways affected by microrganisms living in the human gut and gene expression, immune function, and inflammation that can contribute to a range of cognitive, psychiatric, and neurodegenerative disorders.
Antioxidant therapies may help in the fight against neurodegenerative diseases
A new review examines the potential of antioxidant approaches for the treatment of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis.
Promising results with new gene therapy approach for treating inherited neurodegenerative diseases
A new gene therapy approach designed to replace the enzyme that is deficient in patients with the inherited neurodegenerative disorders Tay-Sachs and Sandhoff diseases successfully delivered the therapeutic gene to the brains of treated mice, restored enzyme function, and extended survival by about 2.5-fold.
Could a new class of fungicides play a role in autism, neurodegenerative diseases?
Scientists at the UNC School of Medicine have found a class of commonly used fungicides that produce gene expression changes similar to those in people with autism and neurodegenerative conditions, including Alzheimer's disease and Huntington's disease.

Related Neurodegenerative Diseases Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Setbacks
Failure can feel lonely and final. But can we learn from failure, even reframe it, to feel more like a temporary setback? This hour, TED speakers on changing a crushing defeat into a stepping stone. Guests include entrepreneur Leticia Gasca, psychology professor Alison Ledgerwood, astronomer Phil Plait, former professional athlete Charly Haversat, and UPS training manager Jon Bowers.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".